Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardinal Fee-For-Service Ultimatum Is Serious, CEO Says

Executive Summary

Cardinal is ready to make good on its threat to cut off drug distribution services for products not covered under a fee-for-service distribution agreement by the end of March, CEO Bob Walter said

You may also be interested in...



Cardinal Drops Eisai; Wholesaler Still Confident In Fee-For-Service Model

Eisai is the first pharmaceutical company to be dropped by Cardinal after failing to accept new terms of payment for the wholesaler

Cardinal Drops Eisai; Wholesaler Still Confident In Fee-For-Service Model

Eisai is the first pharmaceutical company to be dropped by Cardinal after failing to accept new terms of payment for the wholesaler

Wholesaler Distribution Fee Rates May Be Lower Than Planned, Study Says

Drug wholesaler distribution fees may provide lower revenues than expected, a study by Accenture and Goldman Sachs says

Related Content

UsernamePublicRestriction

Register

PS140995

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel